Alethea Biotech Fund, LP
Alethea Capital · adviser of record: Alethea Capital Management, LLC · 2016 vintage
Alethea Biotech Fund, LP is a 2016 venture fund managed by Alethea Capital. It reported $7.6mm in gross assets at year-end 2020, against a peak of $9.4mm in 2019.
- Latest value held
- $7.6mm year-end 2020
- Peak
- $9.4mm year-end 2019
- Fund size
- Not on file
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2020 | $7.6mm | – | -20% |
| 2019 | $9.4mm | – | +12% |
| 2018 | $8.4mm | – | +41% |
| 2017 | $6mm | – | +17% |
| 2016 | $5.1mm | – | – |
Other funds from Alethea Capital
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-4940831029. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.